Granulomas

Clinicians should consider rubella virus as a potential contributor to granulomatous skin disease in both immunodeficient and immunocompetent patients, according to a study.

In the absence of curative or disease-altering therapies, patients with sarcoidosis value interventions that improve their quality of life over those for function or even survival, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.